Evaluate the Safety of Neuronata-R Inj. Suspended With HypoTHermosol FRS (HTS-FRS) in Patients With ALS
Status:
COMPLETED
Trial end date:
2023-11-27
Target enrollment:
Participant gender:
Summary
This clinical trial is a single-center, open-label, and phase I clinical trial to Evaluate the Safety of Neuronata-R Inj. suspended with HypoTHermosol FRS (HTS-FRS) in Patients with Amyotrophic Lateral Sclerosis.